(Q33499141)

27 July 2017

1 reference

title

Low molecular weight heparin(oid)s. Clinical investigations and practical recommendations (English)

1 reference

27 July 2017

Nurmohamed MT

1

1 reference

27 July 2017

ten Cate H

series ordinal

2

1 reference

27 July 2017

ten Cate JW

series ordinal

3

1 reference

27 July 2017

1 May 1997

1 reference

27 July 2017

1 reference

27 July 2017

53

1 reference

27 July 2017

736-751

1 reference

27 July 2017

5

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199753050-00002

27 July 2017

0 references

cites work

Neutralization of enoxaparine-induced bleeding by protamine sulfate

1 reference

12 December 2020

Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172)

1 reference

12 December 2020

Prophylaxis of deep venous thrombosis with a low-molecular-weight heparin (Kabi 2165/Fragmin) in stroke patients.

1 reference

12 December 2020

Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis

1 reference

12 December 2020

Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin.

1 reference

12 December 2020

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

1 reference

12 December 2020

Heparin-induced thrombocytopenia

1 reference

12 December 2020

Prevention and treatment of venous thromboembolism

1 reference

12 December 2020

Placental transfer of low-molecular weight heparin

1 reference

12 December 2020

Prevention of thromboembolism after spinal cord injury using low-molecular-weight heparin.

1 reference

12 December 2020

RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. RD Heparin Arthroplasty Group

1 reference

12 December 2020

A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma.

1 reference

12 December 2020

Prophylaxis of postoperative thromboembolism with low molecular weight heparins.

1 reference

12 December 2020

Deep venous thrombosis and pulmonary embolism in patients with acute spinal cord injury: a comparison with nonparalyzed patients immobilized due to spinal fractures.

1 reference

12 December 2020

Heparin-induced thrombocytopenia and thrombosis

1 reference

12 December 2020

A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.

1 reference

12 December 2020

Partial in vivo neutralisation of plasma anticoagulant effects of Lomoparan (Org 10172) by protamine chloride

1 reference

12 December 2020

Progress in interventional cardiology. Restenosis after elective percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Highly Purified Antithrombin III with Heparin Cofactor Activity Prepared by Disc Electrophoresis

1 reference

12 December 2020

Reduction of reinfarction and angina with use of low-molecular-weight heparin therapy after streptokinase (and heparin) in acute myocardial infarction.

1 reference

12 December 2020

Low molecular weight heparins (LMWH) in the treatment of patients with acute venous thromboembolism

1 reference

12 December 2020

Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis

1 reference

12 December 2020

Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo

1 reference

12 December 2020

Rates of venous thrombosis after general surgery: combined results of randomised clinical trials

1 reference

12 December 2020

Effect of Heparin and Heparin Fractions on Platelet Aggregation

1 reference

12 December 2020

Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery.

1 reference

12 December 2020

Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis

1 reference

12 December 2020

Low molecular weight heparin as thromboprophylaxis in familial thrombophilia during the whole period of pregnancy

1 reference

12 December 2020

In vitro studies of the interaction of heparin, low molecular weight heparin and heparinoids with platelets.

1 reference

12 December 2020

Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration

1 reference

12 December 2020

Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. The Heparin Study in Internal Medicine Group.

1 reference

12 December 2020

The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies

1 reference

12 December 2020

Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study.

1 reference

12 December 2020

Prophylaxis of venous thromboembolism

1 reference

12 December 2020

Starting prophylaxis for venous thromboembolism postoperatively

1 reference

12 December 2020

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.

1 reference

12 December 2020

Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement.

1 reference

12 December 2020

Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke

1 reference

12 December 2020

Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery.

1 reference

12 December 2020

Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group.

1 reference

12 December 2020

Prevention of venous thromboembolism after knee arthroplasty. A randomized, double-blind trial comparing enoxaparin with warfarin.

1 reference

12 December 2020

Low-molecular-weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies

1 reference

12 December 2020

Comparison of the in vivo hemorrhagic and antithrombotic effects of a low antithrombin-III affinity heparin fraction

1 reference

12 December 2020

Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group

1 reference

12 December 2020

Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies.

1 reference

12 December 2020

Partial reversal of low molecular weight heparin (PK 10169) anti-Xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulation.

1 reference

12 December 2020

Low molecular weight heparin(s).

1 reference

12 December 2020

Basic-fibroblast-growth-factor-mediated de novo angiogenesis is more effectively suppressed by low-molecular-weight than by high-molecular-weight heparin.

1 reference

12 December 2020

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery

1 reference

12 December 2020

Pilot study of low-molecular-weight heparin in the treatment of acute ischemic stroke.

1 reference

12 December 2020

Randomized trial of subcutaneous low-molecular-weight heparin CY 216 (Fraxiparine) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism. A dose-ranging study

1 reference

12 December 2020

Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin

1 reference

12 December 2020

Extension and structural variability of the antithrombin-binding sequence in heparin.

1 reference

12 December 2020

Low molecular weight heparin for anticoagulation during haemodialysis in children--a preliminary study.

1 reference

12 December 2020

Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis

1 reference

12 December 2020

Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins

1 reference

12 December 2020

Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect

1 reference

12 December 2020

The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits.

1 reference

12 December 2020

Use of enoxaparin in patients with heparin-induced thrombocytopenia syndrome

1 reference

12 December 2020

Benefit of adding low molecular weight heparin to the conventional treatment of stable angina pectoris. A double-blind, randomized, placebo-controlled trial.

1 reference

12 December 2020

A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study

1 reference

12 December 2020

Fraxiparin for prevention of restenosis after percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic Stroke

1 reference

12 December 2020

A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke

1 reference

12 December 2020

Osteoporosis and vertebral collapse following low-dose, low molecular weight heparin therapy in a young patient.

1 reference

12 December 2020

Structure and biological activity of heparin.

1 reference

12 December 2020

Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis

1 reference

12 December 2020

Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia

1 reference

12 December 2020

Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association

1 reference

12 December 2020

Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis

1 reference

12 December 2020

Osteopenia in pregnancy during long-term heparin treatment: a radiological study post partum

1 reference

12 December 2020

Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association

1 reference

12 December 2020

Low molecular weight heparin

1 reference

12 December 2020

Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity

1 reference

12 December 2020

A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery

1 reference

12 December 2020

Deep venous thrombosis and pulmonary embolism in pregnancy

1 reference

12 December 2020

Anticoagulant therapy by continuous heparinization in newborn and older infants

1 reference

12 December 2020

Thromboembolic prophylaxis with low molecular weight heparin during pregnancy.

1 reference

12 December 2020

Use of a heparinoid in patients with hemorrhagic stroke and thromboembolic disease

1 reference

12 December 2020

Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients

1 reference

12 December 2020

Prevention of deep vein thrombosis after major knee surgery--a randomized, double-blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo

1 reference

12 December 2020

Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis.

1 reference

12 December 2020

Low molecular weight heparin in prevention of perioperative thrombosis

1 reference

12 December 2020

Subcutaneous low-molecular-weight heparin fragmin versus intravenous unfractionated heparin in the treatment of acute non massive pulmonary embolism: an open randomized pilot study.

1 reference

12 December 2020

Large-dose infusions of heparinoid ORG 10172 in ischemic stroke.

1 reference

12 December 2020

10.2165/00003495-199753050-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference